A Study of Dovitinib With Androgen Deprivation Therapy (ADT) in Patients With Metastatic Prostate Cancer Receiving Primary ADT
Clinical trial NCT02065323 · WITHDRAWN
Trial details
- NCT number
- NCT02065323
- Sponsor
- Oscar Goodman, Jr.
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Primary completion
- 2014-08-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.